GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma
出版年份 2017 全文链接
标题
GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 2, Pages 866-879
出版商
Wiley
发表日期
2017-02-01
DOI
10.1002/jcp.25793
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3β and SFRP1
- (2016) Zuoqing Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia
- (2016) S Fathullahzadeh et al. CANCER GENE THERAPY
- Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma
- (2016) M Mohammadi et al. CANCER GENE THERAPY
- Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
- (2016) L Saadatpour et al. CANCER GENE THERAPY
- Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer
- (2016) R Nedaeinia et al. CANCER GENE THERAPY
- Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
- (2016) Reza Salarinia et al. CURRENT CANCER DRUG TARGETS
- Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives
- (2016) Hamed Mirzaei et al. CURRENT MEDICINAL CHEMISTRY
- Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
- (2016) Hamid Mirzaei et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
- (2016) Hamed Mirzaei et al. EUROPEAN JOURNAL OF CANCER
- Curcumin: A new candidate for melanoma therapy?
- (2016) Hamed Mirzaei et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor
- (2016) GENG LIU et al. Molecular Medicine Reports
- MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines
- (2016) ZIRAN WANG et al. ONCOLOGY REPORTS
- MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells
- (2016) ENRICA FABBRI et al. ONCOLOGY REPORTS
- Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
- (2016) Koumudi Naraparaju et al. Oncotarget
- microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5′-untranslated region in neuroblastoma
- (2016) Hongxia Qu et al. Oncotarget
- MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis
- (2016) Min Cheng et al. Oncotarget
- Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease
- (2016) Satish Kumar Ramraj et al. Oncotarget
- Neuroblastoma: Molecular Pathogenesis and Therapy
- (2015) Chrystal U. Louis et al. Annual Review of Medicine
- MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
- (2015) Anneleen Beckers et al. CANCER LETTERS
- The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment
- (2015) Sharareh Gholamin et al. CURRENT PHARMACEUTICAL DESIGN
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2β
- (2015) Kai Wu et al. FEBS LETTERS
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68
- (2015) DONGJU ZHAO et al. Molecular Medicine Reports
- Targeting MYCN IRES in MYCN -amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation
- (2015) Hailong Zhang et al. Molecular Oncology
- miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14
- (2015) Xuan Xiang et al. Oncotarget
- Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
- (2015) Ali Rihani et al. Scientific Reports
- Two independent epigenetic biomarkers predict survival in neuroblastoma
- (2015) Yania Yáñez et al. Clinical Epigenetics
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Abstract 5229: Profiling of circulating miRNAs is a critical prognostic biomarker tool for high-risk neuroblastoma
- (2015) Satish Kumar Ramraj et al. CANCER RESEARCH
- A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells
- (2015) Ketan S. Patil et al. PLoS One
- miR-200a Inhibits Tumor Proliferation by Targeting AP-2γ in Neuroblastoma Cells
- (2014) Shun-Li Gao et al. Asian Pacific Journal of Cancer Prevention
- The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
- (2014) Gaurav Kumar Pandey et al. CANCER CELL
- Anti-GD2 strategy in the treatment of neuroblastoma
- (2014) R.K. Yang et al. DRUGS OF THE FUTURE
- Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis
- (2014) Irene Y. Cheung et al. GENES CHROMOSOMES & CANCER
- Recent insights into the biology of neuroblastoma
- (2014) Gudrun Schleiermacher et al. INTERNATIONAL JOURNAL OF CANCER
- Biomarker Modulations in Children With Neuroblastoma Following Treatment With 131I-mIBG
- (2014) B.S. Imber et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
- (2014) Mickaël Terme et al. PLoS One
- GD2-Targeted Immunotherapy and Radioimmunotherapy
- (2014) Konstantin Dobrenkov et al. SEMINARS IN ONCOLOGY
- MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1
- (2014) LIN CHENG et al. Oncology Letters
- B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma
- (2013) Wan-Ling Ho et al. CANCER SCIENCE
- Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study
- (2013) J. Osman et al. Clinical & Translational Oncology
- -1,4-Galactosyltransferase III Enhances Invasive Phenotypes Via 1-Integrin and Predicts Poor Prognosis in Neuroblastoma
- (2013) H.-H. Chang et al. CLINICAL CANCER RESEARCH
- Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
- (2013) Mahiuddin Ahmed et al. FEBS LETTERS
- Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
- (2013) Anna Alisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
- (2013) Patrick Y. Kim et al. Journal of Proteomics
- MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
- (2013) Laura Creevey et al. Molecular Cancer
- microRNA-202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN-5
- (2013) YU-GUANG LI et al. Molecular Medicine Reports
- MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
- (2013) Marco Lodrini et al. NUCLEIC ACIDS RESEARCH
- Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells
- (2013) TRI BUDI HARTOMO et al. ONCOLOGY REPORTS
- Study of the mechanisms underlying the reversal of multidrug resistance of human neuroblastoma multidrug-resistant cell line SK-N-SH/MDR1 by low-intensity pulsed ultrasound
- (2013) YANHUI SUN et al. ONCOLOGY REPORTS
- Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
- (2013) Danilo Marimpietri et al. PLoS One
- miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis
- (2013) Jingbo Qiao et al. SURGERY
- MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
- (2012) J Ryan et al. BRITISH JOURNAL OF CANCER
- MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
- (2012) Jennifer Lynch et al. CARCINOGENESIS
- Promising Therapeutic Targets in Neuroblastoma
- (2012) K. K. Matthay et al. CLINICAL CANCER RESEARCH
- GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients
- (2012) N. Berois et al. CLINICAL CHEMISTRY
- Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma
- (2012) MEGUMI NOZATO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
- (2012) ALESSANDRO ALLEGRA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
- (2012) Nidale Tarek et al. JOURNAL OF CLINICAL INVESTIGATION
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating microRNAs in cancer: origin, function and application
- (2012) Ruimin Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- N-myc and Noncoding RNAs in Neuroblastoma
- (2012) J. Buechner et al. MOLECULAR CANCER RESEARCH
- microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells
- (2012) H. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs
- (2012) S Das et al. ONCOGENE
- A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and -103, Target the Differentiation Inhibitor ID2
- (2012) Daniela Annibali et al. PLoS One
- Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
- (2012) Anneleen Decock et al. GENOME BIOLOGY
- Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
- (2012) Nai-Kong V. Cheung et al. OncoImmunology
- B4GALNT3 Expression Predicts a Favorable Prognosis and Suppresses Cell Migration and Invasion via β1 Integrin Signaling in Neuroblastoma
- (2011) Wen-Ming Hsu et al. AMERICAN JOURNAL OF PATHOLOGY
- Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
- (2011) Helena Carén et al. BMC CANCER
- MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
- (2011) Amanda Tivnan et al. BMC CANCER
- Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
- (2011) J Buechner et al. BRITISH JOURNAL OF CANCER
- Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCFβ-TRCP in neuroblastoma cells
- (2011) Akanksha Singh et al. CANCER
- Successful Multifold Dose Escalation of Anti-GD2Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study
- (2011) Brian H. Kushner et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Phosphoproteins as Possible Differentiation Markers in All-Trans-Retinoic Acid-Treated Neuroblastoma Cells
- (2011) Giorgia Mandili et al. PLoS One
- A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
- (2011) Nidia Alvarez-Rueda et al. PLoS One
- Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice
- (2010) S J Smith et al. EYE
- MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
- (2010) Niamh H Foley et al. Molecular Cancer
- The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma
- (2010) Pieter Mestdagh et al. MOLECULAR CELL
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
- (2009) J. M. Venstrom et al. CLINICAL CANCER RESEARCH
- MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness
- (2009) Cristina Evangelisti et al. FASEB JOURNAL
- Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
- (2009) Isabella Bray et al. PLoS One
- Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma
- (2008) I. Y. Cheung et al. CLINICAL CANCER RESEARCH
- Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis
- (2008) W.-M. Hsu et al. CLINICAL CANCER RESEARCH
- mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
- (2008) Catarina Träger et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More